Get started
Author

Irene Y. Cheung

Observed names: I Cheung, I Y Cheung, I. Cheung, I. Y. Cheung, I.Y. Cheung, Irene Cheung, Irene Y Cheung
ORCID: 0000-0002-1427-514X
Observed ORCID: 0000-0002-1427-514X
OpenAlex ID: A5083817841
MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
2009 · Hong Xu, Irene Y. Cheung, et al. · Cancer Research · 264
Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
2012 · Nai-Kong V. Cheung, Irene Y. Cheung, et al. · Journal of Clinical Oncology · 263
PDF
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
1998 · N K Cheung, B H Kushner, et al. · Journal of Clinical Oncology · 199
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
2012 · Nai-Kong V. Cheung, Hongfen Guo, et al. · OncoImmunology · 153
PDF
Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
2016 · Konstantin Dobrenkov, Irina Ostrovnaya, et al. · Pediatric Blood & Cancer · 149
Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission
2014 · Brian H. Kushner, Irene Y. Cheung, et al. · Clinical Cancer Research · 144
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
2009 · K Beiske, S A Burchill, et al. · British Journal of Cancer · 130
PDF
KIRandHLAGenotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
2009 · Jeffrey M. Venstrom, Junting Zheng, et al. · Clinical Cancer Research · 129
N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
2001 · Nai-Kong V. Cheung, Brian H Kushner, et al. · Medical and Pediatric Oncology · 129
Humanized 3F8 Anti-G D2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma
2018 · Brian H. Kushner, Irene Y. Cheung, et al. · JAMA Oncology · 126
PDF
FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor
2006 · Nai-Kong V. Cheung, Rebecca Sowers, et al. · Journal of Clinical Oncology · 120
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression
2020 · Irene Y. Cheung, Nai-Kong V. Cheung, et al. · Journal of Clinical Oncology · 112
Key role for myeloid cells: Phase II results of anti‐GD2 antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma
2014 · Nai‐Kong V. Cheung, Irene Y. Cheung, et al. · International Journal of Cancer · 92
PDF
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
2018 · Shakeel Modak, Jean-Benoit Le Luduec, et al. · OncoImmunology · 91
PDF
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.
2001 · J Mora, N K Cheung, et al. · PubMed · 86
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
2020 · Shakeel Modak, Pat Zanzonico, et al. · Journal of Clinical Oncology · 84
Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?
1997 · N K Cheung, G Heller, et al. · Journal of Clinical Oncology · 81
MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas
2011 · Ruimin Huang, Nai‐Kong V. Cheung, et al. · The FASEB Journal · 79
Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
2000 · N K Cheung, H F Guo, et al. · PubMed · 79
Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
1994 · N K Cheung, I Y Cheung, et al. · PubMed · 79
Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.
2001 · I Y Cheung, N K Cheung · PubMed · 78
Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma
2008 · Irene Y. Cheung, Yi Feng, et al. · Clinical Cancer Research · 77
PDF
Activation of Peripheral-Blood Granulocytes Is Strongly Correlated With Patient Outcome After Immunotherapy With Anti-GD2 Monoclonal Antibody and Granulocyte-Macrophage Colony-Stimulating Factor
2011 · Irene Y. Cheung, Katharine Hsu, et al. · Journal of Clinical Oncology · 71
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin
2015 · Brian H. Kushner, Irina Ostrovnaya, et al. · Oncotarget · 64
Novel Markers of Subclinical Disease for Ewing Family Tumors from Gene Expression Profiling
2007 · Irene Y. Cheung, Yi Feng, et al. · Clinical Cancer Research · 64
Works count: 115
Citation count: 4,154
H-index: 38
I10-index: 61
Year
Topic
Type